Cindy X. Cai

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis

Cindy X. Cai, Hema Buddha, Shobha Castelino‐Prabhu et al. · Digestive Diseases and Sciences · 2017 · 73 citations

Medicine, Cell Biology, Pathology +16

Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway

Zhiwei Zhang, Cindy X. Cai · Molecular and Cellular Biochemistry · 2016 · 63 citations

Medicine, Molecular Biology, Nephrology +13

Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin

Zhiwei Zhang, Geetha Maddukuri, Navin Jaipaul et al. · Journal of Critical Care · 2015 · 62 citations

Medicine, Nephrology, Pharmacotherapy +14

Targeting an Early and Substantial Increase in Mean Arterial Pressure Is Critical in the Management of Type 1 Hepatorenal Syndrome: A Combined Retrospective and Pilot Study

Geetha Maddukuri, Cindy X. Cai, Satish Munigala et al. · Digestive Diseases and Sciences · 2013 · 27 citations

Medicine, Surgery, Hemodynamic Management +11